Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Kindred Biosciences to Present at Upcoming Investor Conferences | ||
| By: PR Newswire Association LLC. - 30 Aug 2017 | Back to overview list |
|
SAN FRANCISCO, Aug. 30, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will be presenting at three, upcoming investor conferences in September 2017: 6th Annual Gateway Conference (September 6-7, 2017) Rodman & Renshaw 19th Annual Global Investment Conference (September 11-12, 2017) Ladenburg Thalmann 2017 Healthcare Conference (September 26, 2017) An archived version of the webcasts will be available for 30 days on the Company's website: http://kindredbio.com/investor-relations/events. About Kindred Biosciences Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes. For more information or to download the corporate presentation, visit www.KindredBio.com/LearnMore. Stay connected with KindredBio on Facebook at www.Facebook.com/KindredBio. Contact Russell Radefeld
View original content with multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-upcoming-investor-conferences-300510588.html SOURCE Kindred Biosciences, Inc. 
|
||
|
||
 | Back to overview list | |